|
| Exchange Disseminated Time | Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release titled "Lincoln Pharmaceuticals Ltd. gains market share with technologically advanced Collagen Bio-tech products"
Press Release :
"Lincoln Pharmaceuticals Ltd. (LPL), a world class pharmaceutical company strengthens its position in the Indian pharmaceutical industry with its technologically advanced Collagen Bio-tech products, Medifil and Skin Temp. LPL tied-up with Human Biosciences Inc., Maryland - USA last year for the exclusive marketing and distribution of these two innovative wound care management products in India. Since its entry Into the Indian market, the products have demonstrated to be at least 50% faster in healing wounds, with a 50% reduction in frequency dressing and no scar formation compared to existing products. This has lead to Medifil and Skin Temp acquiring 22% market share in its category in India.
Speaking on the success of the products, Mr. Mahendra G Patel, MD, Lincoln Pharmaceutical Ltd. said, "Our mission at Lincoln Pharmaceuticals is to provide customers with healthcare products of high quality at an affordable price. The introduction of Medifil and Skin Temp in India has enabled customers to benefit from an advanced wound care solution with better recovery and greater ease of use at a reduced cost. We are planning to set up a manufacturing unit in India to increase production and expand our reach so that more people can avail the benefits of these products." |
|
|